- Home
- CRBP vs DSY Comparison
CRBP vs DSY Comparison
Compare CRBP & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- DSY
- Stock Information
- Founded
- CRBP 2009
- DSY 2020
- Country
- CRBP United States
- DSY China
- Employees
- CRBP N/A
- DSY N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- DSY
- Sector
- CRBP Health Care
- DSY
- Exchange
- CRBP Nasdaq
- DSY Nasdaq
- Market Cap
- CRBP 73.4M
- DSY 58.8M
- IPO Year
- CRBP N/A
- DSY N/A
- Fundamental
- Price
- CRBP $5.03
- DSY $1.04
- Analyst Decision
- CRBP Strong Buy
- DSY
- Analyst Count
- CRBP 10
- DSY 0
- Target Price
- CRBP $60.89
- DSY N/A
- AVG Volume (30 Days)
- CRBP 211.7K
- DSY 198.7K
- Earning Date
- CRBP 03-11-2025
- DSY 02-10-2025
- Dividend Yield
- CRBP N/A
- DSY N/A
- EPS Growth
- CRBP N/A
- DSY 120.37
- EPS
- CRBP N/A
- DSY 0.01
- Revenue
- CRBP N/A
- DSY $7,323,356.00
- Revenue This Year
- CRBP N/A
- DSY N/A
- Revenue Next Year
- CRBP $270.01
- DSY N/A
- P/E Ratio
- CRBP N/A
- DSY $83.61
- Revenue Growth
- CRBP N/A
- DSY 16.37
- 52 Week Low
- CRBP $4.92
- DSY $0.75
- 52 Week High
- CRBP $61.90
- DSY $13.47
- Technical
- Relative Strength Index (RSI)
- CRBP 25.32
- DSY 35.13
- Support Level
- CRBP $5.76
- DSY $0.98
- Resistance Level
- CRBP $6.17
- DSY $1.19
- Average True Range (ATR)
- CRBP 0.40
- DSY 0.15
- MACD
- CRBP 0.01
- DSY 0.01
- Stochastic Oscillator
- CRBP 5.33
- DSY 16.04
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.